GAIBANI, PAOLO
 Distribuzione geografica
Continente #
NA - Nord America 4.432
EU - Europa 3.074
AS - Asia 1.751
AF - Africa 231
SA - Sud America 30
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 2
Totale 9.529
Nazione #
US - Stati Uniti d'America 4.417
GB - Regno Unito 747
IT - Italia 632
CN - Cina 616
SE - Svezia 537
SG - Singapore 449
DE - Germania 395
VN - Vietnam 379
IN - India 168
IE - Irlanda 141
UA - Ucraina 128
RU - Federazione Russa 114
FR - Francia 97
ZA - Sudafrica 93
CH - Svizzera 59
FI - Finlandia 50
TG - Togo 49
BG - Bulgaria 44
CI - Costa d'Avorio 44
EE - Estonia 41
JO - Giordania 39
ID - Indonesia 31
NG - Nigeria 31
NL - Olanda 20
BE - Belgio 16
BR - Brasile 13
JP - Giappone 12
KR - Corea 12
RO - Romania 12
CA - Canada 10
AU - Australia 9
IR - Iran 9
HR - Croazia 8
SC - Seychelles 8
PH - Filippine 7
ES - Italia 6
GR - Grecia 6
HK - Hong Kong 6
PE - Perù 6
AT - Austria 5
CL - Cile 5
PK - Pakistan 5
PL - Polonia 5
PT - Portogallo 5
TR - Turchia 5
BD - Bangladesh 4
CO - Colombia 4
LB - Libano 3
NI - Nicaragua 3
TN - Tunisia 3
AR - Argentina 2
KG - Kirghizistan 2
LT - Lituania 2
LY - Libia 2
SA - Arabia Saudita 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
CZ - Repubblica Ceca 1
ET - Etiopia 1
EU - Europa 1
LI - Liechtenstein 1
LV - Lettonia 1
MY - Malesia 1
PA - Panama 1
PR - Porto Rico 1
UZ - Uzbekistan 1
Totale 9.529
Città #
Southend 674
Fairfield 492
Chandler 425
Singapore 397
Ashburn 349
Santa Clara 304
Woodbridge 247
Seattle 233
Dong Ket 212
Wilmington 211
Houston 203
Princeton 193
Cambridge 179
Dublin 139
Ann Arbor 138
Boardman 120
Bologna 89
Jacksonville 84
Padova 75
Nanjing 74
Westminster 62
New York 61
Bern 50
Berlin 49
Bremen 49
Lomé 49
Abidjan 44
Jinan 44
Sofia 44
Helsinki 43
Redwood City 41
Amman 39
Saint Petersburg 39
Pretoria 38
San Diego 37
Milan 36
Turin 34
Beijing 33
Guangzhou 33
Mülheim 32
Abeokuta 31
Rome 31
Shanghai 27
Jakarta 26
Nanchang 24
Shenyang 24
Changsha 22
Des Moines 22
Falls Church 22
Hebei 22
Tianjin 22
Florence 20
Redmond 17
Brussels 16
Jiaxing 16
Verona 16
Chicago 15
Los Angeles 15
Ningbo 15
Tappahannock 15
Zhengzhou 15
Olalla 13
Phoenix 13
Dearborn 10
Hangzhou 10
London 10
San Venanzo 10
Aracaju 9
Haikou 9
Fuzhou 8
Lanzhou 8
Mahé 8
Norwalk 8
Chengdu 7
Fort Worth 7
Kunming 7
Lappeenranta 7
Mumbai 7
Toronto 7
Wuhan 7
Forlì 6
Genoa 6
Hong Kong 6
Taiyuan 6
Boydton 5
Bühl 5
Incheon 5
Kuban 5
Pune 5
Qingdao 5
San Jose 5
Sassari 5
Springfield 5
Taizhou 5
Washington 5
Zagreb 5
Bergamo 4
Bogotá 4
Casalecchio di Reno 4
Frankfurt am Main 4
Totale 6.393
Nome #
Absence of neuroinvasive disease in a liver transplant recipient who acquired West Nile virus (WNV) infection from the organ donor and who received WNV antibodies prophylactically. 208
A rapid and specific real-time RT-PCR assay to identify Usutu virus in human plasma, serum, and cerebrospinal fluid 204
New evidence of cutaneous leishmaniasis in north-eastern Italy 180
Molecular remodeling of potassium channels in fibroblasts from centenarians: a marker of longevity? 172
The central region of the msp gene of Treponema denticola has sequence heterogeneity among clinical samples, obtained from patients with periodontitis 171
Chikungunya: an emerging and spreading arthropod-borne viral disease. 166
Comparative genomic and phylogenetic analysis of the first usutu virus isolate from a human patient presenting with neurological symptoms. 164
Blood culture systems: rapid detection-how and why? 148
Ceftolozane-Tazobactam Treatment of Hypervirulent Multidrug Resistant Pseudomonas aeruginosa Infections in Neutropenic Patients 147
Killing of Treponema denticola by mouse peritoneal macrophages. 145
Carbapenem resistant bacteria in Intensive Care Unit during COVID-19 pandemic: Multicenter before-after cross sectional study 143
A carbapenem-resistant Klebsiella pneumoniae isolate harboring KPC-1 from Italy. 140
Efficacy of corticosteroid treatment for hospitalized patients with severe COVID-19: a multicentre study 137
Development and validation of a prediction model for severe respiratory failure in hospitalized patients with SARS-CoV-2 infection: a multicentre cohort study (PREDI-CO study) 137
Detection of Usutu-virus-specific IgG in blood donors from northern Italy 136
Comparative Usutu and West Nile virus transmission potential by local Culex pipiens mosquitoes in north-western Europe 135
In vivo evolution of resistant subpopulations of KPC-producing Klebsiella pneumoniae during ceftazidime/avibactam treatment 135
Serological and molecular tools to diagnose visceral leishmaniasis: 2-years' experience of a single center in Northern Italy 134
Treponema Denticola alters cell vitality and induces HO1 and HSP70 expression in porcine Aortic Endothelial cells. 133
Toscana virus infections in northern Italy: laboratory and clinical evaluation. 133
Antiviral activity of interferon-based combination therapy in critically ill patients with COVID-19: Preliminary observations 133
Inflammatory cytokine expression is associated with chikungunya virus resolution and symptom severity. 131
Clinical application of Bruker Biotyper MALDI-TOF/MS system for real-time identification of KPC production in Klebsiella pneumoniae clinical isolates 130
Diagnosis of west nile virus human infections: overview and proposal of diagnostic protocols considering the results of external quality assessment studies. 129
Bloodstream infection caused by KPC-producing Klebsiella pneumoniae resistant to ceftazidime/avibactam: epidemiology and genomic characterization 126
Phylogenetic analysis of West Nile virus isolates, Italy, 2008-2009. 120
False-positive transcription-mediated amplification assay detection of West Nile virus in blood from a patient with viremia caused by an Usutu virus infection. 118
Evaluation of Phenotypic and Genotypic Approaches for the Detection of Class A and Class B Carbapenemases inEnterobacteriaceae 117
Diagnostic methods for CHIKV based on serological tools 116
Single-reaction, multiplex, real-time rt-PCR for the detection, quantitation, and serotyping of dengue viruses. 115
Microbiological and pharmacological tests on new antibiotic-loaded PMMA-based composites for the treatment of osteomyelitis 113
Mosquito, bird and human surveillance of west nile and usutu viruses in Emilia-Romagna region (Italy) in 2010. 113
Recent Advances in the Evaluation of Serological Assays for the Diagnosis of SARS-CoV-2 Infection and COVID-19 113
Human infection with highly pathogenic a(H7N7) avian influenza virus, Italy, 2013 112
Outbreak of Citrobacter freundii carrying VIM-1 in an Italian Hospital, identified during the carbapenemases screening actions, June 2012. 110
Development of a broad-range 23S rDNA real-time PCR assay for the detection and quantification of pathogenic bacteria in human whole blood and plasma specimens. 109
Carbapenemase-producing Enterobacterales: changing epidemiology in a highly endemic Italian area 109
Persistence of anti-west nile virus-specific antibodies among asymptomatic blood donors in Northeastern Italy. 108
Heterogeneity of West Nile virus genotype 1a in Italy, 2011 107
Comparative serum bactericidal activity of meropenem-based combination regimens against extended-spectrum beta-lactamase and KPC-producing Klebsiella pneumoniae 107
Two cases of relapsed HIV-associated visceral leishmaniasis successfully treated with combination therapy 105
Infections in liver and lung transplant recipients: A national prospective cohort 104
Cefiderocol treatment for carbapenem-resistant Acinetobacter baumannii infection in the ICU during the COVID-19 pandemic: a multicentre cohort study 104
Detection of specific antibodies against West Nile and Usutu viruses in healthy blood donors in northern Italy, 2010-2011. 102
Imported cases of dengue virus infection: Emilia-Romagna, Italy, 2010. 102
COVID-19 in patients with HIV-1 infection: a single-centre experience in northern Italy 102
Clinical application of a molecular method based on real time RT-PCR for detection od influenza A(H1N1)v 101
Retrospective screening of solid organ donors in Italy, 2009, reveals unpredicted circulation of West Nile virus. 98
Seroprevalence of West Nile virus-specific antibodies in a cohort of blood donors in northeastern Italy 98
Persistence of anti-chikungunya virus-specific antibodies in a cohort of patients followed from the acute phase of infection after the 2007 outbreak in Italy. 98
Evaluation of matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of KPC-producing Klebsiella pneumoniae 98
Draft Genome Sequences of Two Multidrug Resistant Klebsiella pneumoniae ST258 Isolates Resistant to Colistin. 96
Outbreak of NDM-1-producing Enterobacteriaceae in northern Italy, July to August 2011. 95
A novel IncA plasmid carrying blaVIM-1 in a Kluyvera cryocrescens strain 93
A descriptive case series of PK/PD target attainment and microbiological outcome in critically ill patients with documented severe XDR Acinetobacter baumannii BSI and/or VAP treated with cefiderocol 93
null 93
Major surface protein complex of Treponema denticola induces the production of tumor necrosis factor alpha, interleukin-1beta, interleukin-6 and matrix metalloproteinase 9by primary human peripheral blood monocytes. 92
In vitro interaction of ceftazidime–avibactam in combination with different antimicrobials against KPC-producing Klebsiella pneumoniae clinical isolates 91
The experience of West Nile virus integrated surveillance system in the Emilia-Romagna region: five years of implementation, Italy, 2009 to 2013 89
A descriptive pharmacokinetic/pharmacodynamic analysis of continuous infusion ceftazidime-avibactam for treating DTR gram-negative infections in a case series of critically ill patients undergoing continuous veno-venous haemodiafiltration (CVVHDF) 86
Draft Genome of Klebsiella pneumoniae Sequence Type 512, a Multidrug-Resistant Strain Isolated during a Recent KPC Outbreak in Italy. 85
Successful containment and infection control of a Carbapenem-resistant Klebsiella pneumoniae outbreak in an Italian hospital 85
Do mosquito-associated bacteria of the genus Asaia circulate in humans? 82
Respiratory bacterial co-infections in intensive care unit-hospitalized COVID-19 patients: Conventional culture vs BioFire FilmArray pneumonia Plus panel 82
Rectal screening of carbapenemase-producing Enterobacteriaceae: a proposed workflow 81
West Nile virus circulation in Emilia-Romagna, Italy: the integrated surveillance system 2009. 79
Usutu virus infection in a patient who underwent orthotropic liver transplantation, Italy, August- September 2009. 78
Humans parasitized by the hard tick Ixodes ricinus are seropositive to Midichloria mitochondrii: is Midichloria a novel pathogen, or just a marker of tick bite? 78
Detection of West Nile virus RNA (lineages 1 and 2) in an external quality assessment programme for laboratories screening blood and blood components for West Nile virus by nucleic acid amplification testing. 77
Phenotypic and genotypic characterization of Klebsiella pneumoniae strains with reduced susceptibiliy to carbapenems 76
Rapid increase of carbapenemase-producing Klebsiella pneumoniae strains in a large Italian hospital: surveillance period 1 March - 30 September 2010. 74
Successful Treatment of Bacteremia and Ventilator-Associated Pneumonia Caused by KPC/OXA-48-like Klebsiella pneumoniae Co-Producer with a Continuous Infusion of High-Dose Meropenem Plus Fosfomycin Guided by Real-Time Therapeutic Drug Monitoring 73
Clinical consequences of very major errors with semi-automated testing systems for antimicrobial susceptibility of carbapenem-resistant Enterobacterales 72
Serodiagnosis of visceral leishmaniasis in northeastern italy: Evaluation of seven serological tests 71
The Gut Microbiota of Critically Ill Patients With COVID-19 70
Serum bactericidal titres for monitoring antimicrobial therapy: current status and potential role in the management of multidrug-resistant Gram-negative infections 69
Real-Time Optimization of Pharmacodynamic Target Attainment at Infection Site during Treatment of Post-Neurosurgical Ventriculitis Caused by Carbapenem-Resistant Gram Negatives with Ceftazidime–Avibactam-Based Regimens: A Report of Two Cases 68
Successful Treatment of Bloodstream Infection due to a KPC-Producing Klebsiella Pneumoniae Resistant to Imipenem/Relebactam in a Hematological Patient 66
Retrospective screening of serum and cerebrospinal fluid samples from patients with acute meningo-encephalitis does not reveal past Japanese encephalitis virus infection, Emilia Romagna, Italy, 2011 66
Critically ill patients with COVID-19 show lung fungal dysbiosis with reduced microbial diversity in Candida spp colonized patients 62
Colonization by ceftazidime/avibactam-resistant KPC-producing Klebsiella pneumoniae following therapy in critically ill patients 59
Seroprevalence of West Nile virus antibodies in blood donors living in the metropolitan area of Milan, Italy, 2009-2011. 58
Evaluation of five carbapenemase detection assays for Enterobacteriaceae harbouring bla KPC variants associated with ceftazidime/avibactam resistance 58
Epidemiology of Meropenem/Vaborbactam Resistance in KPC-Producing Klebsiella pneumoniae Causing Bloodstream Infections in Northern Italy, 2018 55
Suboptimal drug exposure leads selection of different subpopulations of ceftazidime/avibactam-resistant KPC-producing Klebsiella pneumoniae in a critically ill patient 52
Resistance to Ceftazidime/Avibactam, Meropenem/Vaborbactam and Imipenem/Relebactam in Gram-Negative MDR Bacilli: Molecular Mechanisms and Susceptibility Testing 50
A novel method to evaluate ceftazidime/avibactam therapy in patients with carbapenemase-producing Enterobactericeae (CPE) bloodstream infections 47
Whole Genome Sequencing of a Chlamydia trachomatis Strain Responsible for a Case of Rectal Lymphogranuloma Venereum in Italy 43
In vitro synergistic activity of meropenem/vaborbactam in combination with ceftazidime/avibactam against KPC-producing Klebsiella pneumoniae 41
Novel CMY-186 variant conferring cross-resistance to cefiderocol and ceftazidime/avibactam in Klebsiella pneumoniae from a critically ill patient during cefiderocol and ceftazidime/avibactam treatment 39
A descriptive pharmacokinetic/pharmacodynamic analysis of continuous infusion meropenem/vaborbactam in the treatment of critically ill patients with documented KPC-producing Klebsiella pneumoniae ventilator-associated pneumonia 39
Pharmacokinetic/Pharmacodynamic Analysis of Continuous-Infusion Fosfomycin in Combination with Extended-Infusion Cefiderocol or Continuous-Infusion Ceftazidime-Avibactam in a Case Series of Difficult-to-Treat Resistant Pseudomonas aeruginosa Bloodstream Infections and/or Hospital-Acquired Pneumonia 36
Evaluation of synergistic activity of fosfomycin in combination with novel ß-lactams/ß-lactamase inhibitor combinations (βL-βLICs) against KPC-producing Klebsiella pneumoniae clinical isolates 36
Genome characterization of a Klebsiella pneumoniae co-producing OXA-181 and KPC-121 resistant to ceftazidime/avibactam, meropenem/vaborbactam, imipenem/relebactam and cefiderocol isolated from a critically ill patient 34
Epidemiology and In Vitro Activity of Ceftazidime/Avibactam, Meropenem/Vaborbactam and Imipenem/Relebactam against KPC-Producing K. pneumoniae Collected from Bacteremic Patients, 2018 to 2020 33
Dynamic evolution of imipenem/relebactam resistance in a KPC-producing Klebsiella pneumoniae from a single patient during ceftazidime/avibactam-based treatments 30
The lower respiratory tract microbiome of critically ill patients with COVID-19 30
Pharmacokinetics/pharmacodynamics of cefiderocol administered by continuous infusion in a case series of critically ill patients with carbapenem-resistant Acinetobacter baumannii infections undergoing continuous venovenous haemodiafiltration (CVVHDF) 28
Genomic epidemiology of Klebsiella pneumoniae: the Italian scenario, and novel insights into the origin and global evolution of resistance to carbapenem antibiotics. 26
In vitro activity of imipenem-relebactam against KPC-producing Klebsiella pneumoniae resistant to ceftazidime-avibactam and/or meropenem-vaborbactam 25
Totale 9.657
Categoria #
all - tutte 28.514
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.514


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.283 0 0 0 0 0 171 223 284 284 113 87 121
2020/20211.289 295 70 69 43 29 26 21 69 118 57 55 437
2021/20221.748 147 51 76 208 126 94 48 156 71 179 344 248
2022/20232.007 185 214 102 276 171 128 59 128 344 99 163 138
2023/2024826 50 96 62 88 64 173 47 62 26 73 44 41
2024/20251.475 119 361 232 218 427 118 0 0 0 0 0 0
Totale 9.837